CLINICAL SPOTLIGHT
Mariusz Kruk, MD, PhD
Chief Medical Officer
"I am proud to lead our commitment to advancing patient care through innovative medical devices designed for closing arterial access sites following interventional cardiac catheterizations. Our cutting-edge solutions prioritize patient safety, enhance recovery, and reduce complications, enabling the highest standard of care. We are dedicated to transforming the landscape of interventional cardiology by ensuring that our products meet the evolving needs of both clinicians and patients."
Radial artery access
Manual Closure device
Simpliradial®
Globally unique Radial Artery Compression Device
Novel, intuitive, out-of-the-box solution
IP protection – patent granted
Patented under patent families:
WO2013060883, WO2020169573
CE pending
Automatic Robotic Closure device
First-in-class automated access site management robot under development - simpliactive bot.
Radial puncture closure bot-high-tech innovation. Used directly on radial puncture after cardiac catheterization procedure, works with the reusable module.
Initially simpliactive solution will work as a standalone bot.
Patented under patent family WO2015193847.
Simpliactive bots & platform
Simpliactive bots will be integrated into a comprehnsive remote patient monitoring simpliactive platform.
Novel class of medical devices at the interface of arteriotomy closure, cathlab robotization and remote patient monitoring.
Capable to respond to critical market needs.
Big data and self-optimization using AI algorithms.
Simpliactive bots – IP PROTECTION 1st layer
patents granted
Simpliactive bots – IP PROTECTION 2st layer
patents pending
